We are live on ! Find out more
HQL

abrdn Life Sciences Investors

65 hedge funds and large institutions have $93.8M invested in abrdn Life Sciences Investors in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 17

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0.62% less ownership

Funds ownership: 20.87%20.25% (-0.62%)

3% less capital invested

Capital invested by funds: $97M → $93.8M (-$3.22M)

2% less funds holding

Funds holding: 6665 (-1)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
65
Holders Change
-1
Holders Change %
-1.52%
% of All Funds
1.14%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
12
Increased
27
Reduced
17
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NIM
1
Needham Investment Management
New York
$9.36M
AAM
2
Advisors Asset Management
Colorado
$8.25M +$902K +43,754 +12%
Wells Fargo
3
Wells Fargo
California
$7.98M -$715K -34,675 -8%
Morgan Stanley
4
Morgan Stanley
New York
$7.8M -$573K -27,783 -7%
FHA
5
Flagship Harbor Advisors
Massachusetts
$6.35M +$368K +17,836 +6%
MC
6
Matisse Capital
Oregon
$6.29M
1832 Asset Management
7
1832 Asset Management
Ontario, Canada
$5.94M -$2.87M -139,296 -31%
Lazard Asset Management
8
Lazard Asset Management
New York
$4.03M
Cohen & Steers
9
Cohen & Steers
New York
$3.26M -$1.23M -59,445 -26%
1CP
10
1607 Capital Partners
Virginia
$3.15M -$891K -43,245 -21%
Osaic Holdings
11
Osaic Holdings
Arizona
$2.69M +$51.1K +2,478 +2%
Cetera Investment Advisers
12
Cetera Investment Advisers
Illinois
$2.59M +$741K +35,957 +38%
UBS Group
13
UBS Group
Switzerland
$2.4M +$346K +16,784 +16%
LPL Financial
14
LPL Financial
California
$2.32M +$276K +13,411 +13%
Invesco
15
Invesco
Georgia
$2.13M +$479K +23,251 +27%
AUB
16
Atlantic Union Bankshares
Virginia
$1.97M +$1.73M +83,891 +519%
Ameriprise
17
Ameriprise
Minnesota
$1.81M +$72.5K +3,517 +4%
Stifel Financial
18
Stifel Financial
Missouri
$1.48M -$301K -14,591 -16%
1WA
19
180 Wealth Advisors
Washington
$1.26M +$131K +6,359 +11%
RJA
20
Raymond James & Associates
Florida
$1.21M +$627K +30,412 +98%
RJFSA
21
Raymond James Financial Services Advisors
Florida
$1.06M +$131K +6,375 +13%
Janney Montgomery Scott
22
Janney Montgomery Scott
Pennsylvania
$835K +$12.5K +605 +1%
Commonwealth Equity Services
23
Commonwealth Equity Services
Massachusetts
$821K +$170K +8,231 +25%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$752K +$51.6K +2,506 +7%
Citigroup
25
Citigroup
New York
$739K +$110K +5,337 +17%

HQL Hedge Fund Activity: Q1 2021 in Review

65 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2021, worth a combined $93.8M — down 3.3% from $97M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new HQL positions and 11 closed out — a net gain of 1 holder — while 27 added to existing stakes and 17 trimmed.

The largest buyer was Atlantic Union Bankshares, adding an estimated $1.73M. The largest seller was 1832 Asset Management, cutting an estimated $2.87M.

  • 65 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2021, down from 66 in Q4 2020.
  • Funds reported $93.8M of abrdn Life Sciences Investors stock for Q1 2021, down 3.3% quarter-over-quarter.
  • 12 funds opened new abrdn Life Sciences Investors positions in Q1 2021 and 11 closed out, a net change of +1 holder.
  • The largest abrdn Life Sciences Investors buyer in Q1 2021 was Atlantic Union Bankshares, an estimated $1.73M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2021 was 1832 Asset Management, an estimated $2.87M sold.

Based on aggregated 13F filings for Q1 2021.